The N Domain of Human Angiotensin-I-converting Enzyme: THE ROLE OF N-GLYCOSYLATION AND THE CRYSTAL STRUCTURE IN COMPLEX WITH AN N DOMAIN-SPECIFIC PHOSPHINIC INHIBITOR, RXP407
about
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeThe structure of human α-2,6-sialyltransferase reveals the binding mode of complex glycansN-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetesNovel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptideMolecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptidesFragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitorsCrystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzymeMolecular and Thermodynamic Mechanisms of the Chloride-dependent Human Angiotensin-I-converting Enzyme (ACE)Interkingdom Pharmacology of Angiotensin-I Converting Enzyme Inhibitor Phosphonates Produced by ActinomycetesThe toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiaeAn angiotensin I-converting enzyme mutation (Y465D) causes a dramatic increase in blood ACE via accelerated ACE sheddingACE for all - a molecular perspectiveInhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies.A novel angiotensin I-converting enzyme mutation (S333W) impairs N-domain enzymatic cleavage of the anti-fibrotic peptide, AcSDKP.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.Absence of cell surface expression of human ACE leads to perinatal death.Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitorsCrystal structure of a peptidyl-dipeptidase K-26-DCP from Actinomycete in complex with its natural inhibitor.N-acetyl-seryl-aspartyl-lysyl-proline inhibits diabetes-associated kidney fibrosis and endothelial-mesenchymal transition.The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?Crystal structures of sampatrilat and sampatrilat-Asp in complex with human ACE - a molecular basis for domain selectivity.
P2860
Q24306614-E8F3B951-D6AF-4388-84D6-FC982D9DB438Q24321677-E5F1DFC6-EEDF-4168-B33C-B2C9D758634DQ27008887-E215CC51-3049-492B-A1F4-F7F91484C846Q27667064-52D8FC17-FEE1-462E-891A-7ACEADF897F5Q27674442-7CA826C2-83C1-4B2C-A2DF-26E606988566Q27679900-A2723F1F-0C37-4C22-8592-E2C64F7E444BQ27680712-8A207FBD-E654-4A77-9A9B-A6EFE98B1126Q27680735-D6B521F5-7DE6-4F9F-809E-D5919CB3D5CBQ27684235-E6E2FEE4-612F-4654-A940-4D70ABAD46D4Q29198329-FB2E837D-7CAF-4429-BC56-7A7D66ABE102Q31037765-C8A63B92-6BA9-473E-A883-268C6E098CE0Q34195870-6A6BE635-87FC-4D06-936E-FA5DC7CAAA99Q34490095-43ED21F2-AF7E-4E52-BA3C-F5E5E9FBAE11Q35088357-C4F422D8-4FC6-4D06-9B84-C0F731F34155Q35174495-DB57E47D-EC99-42E5-8C0F-6939DA5924CEQ36099917-F87EA21F-F6A2-41DC-AB65-E4197E90B1F8Q37107046-ED2ECE71-3D9A-4597-B1F0-A159C98D58C6Q37593031-9C6A0283-0375-4A0A-B4CE-32BF509DCAA0Q37962590-71E535CF-3171-4E7D-B068-F4B509BB3C34Q39277481-09EF43FC-7FA8-48A9-BD52-430E5C163B56Q42116033-FB7618E8-94A8-46D2-A46F-2EA4E887BBCAQ52347539-95CC3C3C-D719-474C-A322-63419F07C6E9Q52373573-5D964409-1577-48E8-98FD-D78E86D38B8A
P2860
The N Domain of Human Angiotensin-I-converting Enzyme: THE ROLE OF N-GLYCOSYLATION AND THE CRYSTAL STRUCTURE IN COMPLEX WITH AN N DOMAIN-SPECIFIC PHOSPHINIC INHIBITOR, RXP407
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The N Domain of Human Angioten ...... C PHOSPHINIC INHIBITOR, RXP407
@ast
The N Domain of Human Angioten ...... C PHOSPHINIC INHIBITOR, RXP407
@en
The N Domain of Human Angioten ...... C PHOSPHINIC INHIBITOR, RXP407
@nl
type
label
The N Domain of Human Angioten ...... C PHOSPHINIC INHIBITOR, RXP407
@ast
The N Domain of Human Angioten ...... C PHOSPHINIC INHIBITOR, RXP407
@en
The N Domain of Human Angioten ...... C PHOSPHINIC INHIBITOR, RXP407
@nl
prefLabel
The N Domain of Human Angioten ...... C PHOSPHINIC INHIBITOR, RXP407
@ast
The N Domain of Human Angioten ...... C PHOSPHINIC INHIBITOR, RXP407
@en
The N Domain of Human Angioten ...... C PHOSPHINIC INHIBITOR, RXP407
@nl
P2093
P2860
P921
P356
P1476
The N Domain of Human Angioten ...... C PHOSPHINIC INHIBITOR, RXP407
@en
P2093
Colin S Anthony
Dimitris Georgiadis
Edward D Sturrock
Hazel R Corradi
K Ravi Acharya
Pierre Redelinghuys
Sylva L U Schwager
Vincent Dive
P2860
P304
P356
10.1074/JBC.M110.167866
P407
P577
2010-11-12T00:00:00Z